why choose us

First received: June 12, 2023

Clinical Trial: Assessment of Geriatric Evaluations Impact on New AML Guidance

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: AML, Adult

Study Type: OBSERVATIONAL


Official Title: AGE-ING (Assessment of Geriatric Evaluations Impact on New AML Guidance) Study

Brief Summary: The goal of the study is to measure physiologic age (there is no current formal definition but is meant to imply that patients should be evaluated holistically rather than on age alone) at baseline in newly diagnosed AML patients over 50 years receiving either intensive or non-intensive treatment.This information will be used to evaluate toxicity, early mortality, remission rates and long term survival.

Read more